ポスター：Genedataを活用したRNA治療薬の開発

Boston, MA, USA
March 9, 2023

Genedata Biopharma Platformは、全てのデータの取り込みと解析を加速させることで、新規RNA治療薬候補をより早く次のステップへ進めることを可能にします。データインテグリティを保証し、ワークフローを自動化するとともに、AI/MLの活用に不可欠な構造化データ基盤として機能します。

The unprecedented pace of development and the rapid deployment of mRNA-based vaccines during the pandemic demonstrated the efficacy and economic viability of RNA therapeutics. Beyond vaccines, RNA technology has potential in many therapeutic areas, for example enzyme-replacement therapy (ERT), immuno-oncology, and gene editing approaches. The widespread application of RNA technologies requires optimization of the RNA cargo and its delivery system which affects pharmacokinetics, tissue targeting, and therapeutic utility. However, comprehensive characterization and evaluation of a vast number of potential molecules and delivery systems is challenging and requires a specialized data infrastructure for efficient R&D. The Genedata Biopharma Platform enables timesaving capture and analysis of all data required to rapidly progress new RNA therapeutic candidates. The platform ensures data integrity, enables maximum workflow automation, and serves as an essential structured data foundation for AI/ML.